Sfoglia per Rivista CANCER CHEMOTHERAPY AND PHARMACOLOGY
Cisplatin, epirubicin, and lonidamine combination regimen as first-line chemotherapy for metastatic breast cancer: a pilot study.
1998-01-01 Dogliotti, L; Danese, S; Berruti, Alfredo; Zola, P; Buniva, T; Bottini, A; Richiardi, G; Moro, G; Farris, A; Baù, Mg; Porcile, G.
Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer: a phase II study.
2003-01-01 Donadio, M; Ardine, M; Berruti, Alfredo; Ritorto, G; Fea, E; Mistrangelo, M; Coccorullo, Z; Bergnolo, P; Comandone, A; Bertetto, O.
Gemcitabine plus celecoxib (GECO) in advanced pancreatic cancer: a phase II trial
2006-01-01 Ferrari, Vittorio Domenico; Francesca, Valcamonico; Vito, Amoroso; Edda, Simoncini; Lucia, Vassalli; Patrizia, Marpicati; Giovanni, Rangoni; Salvatore, Grisanti; Tiberio, Guido Alberto Massimo; Franco, Nodari; Carla, Strina; Marini, Giovanni
Liposomal-daunorubicin plasmatic and renal disposition in patients with acute leukemia.
2000-01-01 Pea, F; Russo, Domenico; Michieli, M; Baraldo, M; Ermacora, A; Damiani, D; Baccarani, M; Furlanut, M.
A multi-centre retrospective review of second-line therapy in advanced pancreatic adenocarcinoma
2008-01-01 Reni, M; Berardi, R; Mambrini, A; Pasetto, L; Cereda, S; Ferrari, V D; Cascinu, S; Cantore, M; Mazza, E; Grisanti, S
Paclitaxel administration on days 1 and 8 every 21 days in anthracycline-pretreated metastatic breast cancer patients. A multicenter phase II trial
2001-01-01 Donadio, M.; Manzin, E.; Berruti, A.; Bottini, A.; Gorzegno, G.; Danese, S.; Defabiani, E.; Sarobba, M. G.; Lorusso, V.; Castiglione, F.; Moro, G.; Bertetto, O.; Bumma, C.; Dogliotti, L.
Second-line chemotherapy with weekly paclitaxel and gemcitabine in patients with small-cell lung cancer pretreated with platinum and etoposide: a single institution phase II trial
2006-01-01 Dongiovanni, V; Buffoni, L; Berruti, Alfredo; Dongiovanni, D; Grillo, R; Barone, C; Addeo, A; Fissore, C; Bertetto, O.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Cisplatin, epirubicin, and lonidamine combination regimen as first-line chemotherapy for metastatic breast cancer: a pilot study. | 1-gen-1998 | Dogliotti, L; Danese, S; Berruti, Alfredo; Zola, P; Buniva, T; Bottini, A; Richiardi, G; Moro, G; Farris, A; Baù, Mg; Porcile, G. | |
Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer: a phase II study. | 1-gen-2003 | Donadio, M; Ardine, M; Berruti, Alfredo; Ritorto, G; Fea, E; Mistrangelo, M; Coccorullo, Z; Bergnolo, P; Comandone, A; Bertetto, O. | |
Gemcitabine plus celecoxib (GECO) in advanced pancreatic cancer: a phase II trial | 1-gen-2006 | Ferrari, Vittorio Domenico; Francesca, Valcamonico; Vito, Amoroso; Edda, Simoncini; Lucia, Vassalli; Patrizia, Marpicati; Giovanni, Rangoni; Salvatore, Grisanti; Tiberio, Guido Alberto Massimo; Franco, Nodari; Carla, Strina; Marini, Giovanni | |
Liposomal-daunorubicin plasmatic and renal disposition in patients with acute leukemia. | 1-gen-2000 | Pea, F; Russo, Domenico; Michieli, M; Baraldo, M; Ermacora, A; Damiani, D; Baccarani, M; Furlanut, M. | |
A multi-centre retrospective review of second-line therapy in advanced pancreatic adenocarcinoma | 1-gen-2008 | Reni, M; Berardi, R; Mambrini, A; Pasetto, L; Cereda, S; Ferrari, V D; Cascinu, S; Cantore, M; Mazza, E; Grisanti, S | |
Paclitaxel administration on days 1 and 8 every 21 days in anthracycline-pretreated metastatic breast cancer patients. A multicenter phase II trial | 1-gen-2001 | Donadio, M.; Manzin, E.; Berruti, A.; Bottini, A.; Gorzegno, G.; Danese, S.; Defabiani, E.; Sarobba, M. G.; Lorusso, V.; Castiglione, F.; Moro, G.; Bertetto, O.; Bumma, C.; Dogliotti, L. | |
Second-line chemotherapy with weekly paclitaxel and gemcitabine in patients with small-cell lung cancer pretreated with platinum and etoposide: a single institution phase II trial | 1-gen-2006 | Dongiovanni, V; Buffoni, L; Berruti, Alfredo; Dongiovanni, D; Grillo, R; Barone, C; Addeo, A; Fissore, C; Bertetto, O. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile